Cadence Pharmaceuticals, Inc. (CADX) Posts Q3 Loss of 34c/Share

November 3, 2011 4:54 PM EDT
Cadence Pharmaceuticals, Inc. (NASDAQ: CADX) reported Q3 EPS of ($0.34), $0.02 better than the analyst estimate of ($0.36).


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings